UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Flagship Harbor Advisors LLC

Flagship Harbor Advisors LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 8.0% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,091 shares of the healthcare conglomerate’s stock after buying an additional 451 shares during the quarter. Flagship Harbor Advisors LLC’s holdings in UnitedHealth Group were worth $3,128,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. GSA Capital Partners LLP bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $642,000. Rowland & Co. Investment Counsel ADV bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $169,000. Unigestion Holding SA grew its holdings in shares of UnitedHealth Group by 25.9% during the fourth quarter. Unigestion Holding SA now owns 4,786 shares of the healthcare conglomerate’s stock valued at $2,403,000 after purchasing an additional 986 shares during the last quarter. IHT Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 9.9% during the fourth quarter. IHT Wealth Management LLC now owns 3,837 shares of the healthcare conglomerate’s stock valued at $1,927,000 after purchasing an additional 345 shares during the last quarter. Finally, Banco de Sabadell S.A grew its holdings in shares of UnitedHealth Group by 43.1% during the fourth quarter. Banco de Sabadell S.A now owns 10,402 shares of the healthcare conglomerate’s stock valued at $5,235,000 after purchasing an additional 3,132 shares during the last quarter. Institutional investors and hedge funds own 87.25% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on UNH. Credit Suisse Group increased their price objective on UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. SVB Leerink increased their price objective on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. Mizuho increased their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, August 10th. BMO Capital Markets increased their price objective on UnitedHealth Group from $600.00 to $610.00 in a report on Wednesday, July 20th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a research note on Thursday, September 8th. Three analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $586.40.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the transaction, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the transaction, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Stephen J. Hemsley sold 99,312 shares of the stock in a transaction on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the transaction, the director now directly owns 787,372 shares in the company, valued at $420,669,238.44. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 139,051 shares of company stock valued at $74,450,958. 0.40% of the stock is owned by insiders.

UnitedHealth Group Price Performance

UNH opened at $517.46 on Friday. The stock has a fifty day moving average of $530.11 and a 200-day moving average of $512.45. The firm has a market capitalization of $484.02 billion, a P/E ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet Rating) last released its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The company had revenue of $80.33 billion during the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $4.70 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th were paid a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.28%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.46%.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.